Significance of atypical nodules upgraded to category 3 in Prostate Imaging Reporting and Data System version 2.1 for prostate cancer diagnosis

International Journal of UrologyEarly View Urological Note Significance of atypical nodules upgraded to category 3 in Prostate Imaging Reporting and Data System version 2.1 for prostate cancer diagnosis Shintaro Asai MD, Shintaro Asai MD orcid.org/0009-0002-5859-9960 Department of Urology, Tokyo Medical and Dental University, Tokyo, JapanSearch for more papers by this authorMasaki Kobayashi MD, Corresponding Author Masaki Kobayashi MD [email protected] orcid.org/0000-0003-2738-9792 Department of Urology, Tokyo Medical and Dental University, Tokyo, JapanSearch for more papers by this authorShohei Fukuda MD, PhD, Shohei Fukuda MD, PhD Department of Urology, Tokyo Medical and Dental University, Tokyo, JapanSearch for more papers by this authorKoichiro Kimura MD, PhD, Koichiro Kimura MD, PhD Department of Radiology, Tokyo Medical and Dental University, Tokyo, JapanSearch for more papers by this authorSoichiro Yoshida MD, PhD, Soichiro Yoshida MD, PhD Department of Urology, Tokyo Medical and Dental University, Tokyo, JapanSearch for more papers by this authorYasuhisa Fujii MD, PhD, Yasuhisa Fujii MD, PhD orcid.org/0000-0002-6761-3229 Department of Urology, Tokyo Medical and Dental University, Tokyo, JapanSearch for more papers by this author Shintaro Asai MD, Shintaro Asai MD orcid.org/0009-0002-5859-9960 Department of Urology, Tokyo Medical and Dental University, Tokyo, JapanSearch for more papers by this authorMasaki Kobayashi MD, Corresponding Author Masaki Kobayashi MD [email protected] orcid.org/0000-0003-2738-9792 Department of Urology, Tokyo Medical and Dental University, Tokyo, JapanSearch for more papers by this authorShohei Fukuda MD, PhD, Shohei Fukuda MD, PhD Department of Urology, Tokyo Medical and Dental University, Tokyo, JapanSearch for more papers by this authorKoichiro Kimura MD, PhD, Koichiro Kimura MD, PhD Department of Radiology, Tokyo Medical and Dental University, Tokyo, JapanSearch for more papers by this authorSoichiro Yoshida MD, PhD, Soichiro Yoshida MD, PhD Department of Urology, Tokyo Medical and Dental University, Tokyo, JapanSearch for more papers by this authorYasuhisa Fujii MD, PhD, Yasuhisa Fujii MD, PhD orcid.org/0000-0002-6761-3229 Department of Urology, Tokyo Medical and Dental University, Tokyo, JapanSearch for more papers by this author First published: 12 February 2024 https://doi.org/10.1111/iju.15421Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. CONFLICT OF INTEREST STATEMENT The authors have no conflicts of interest to declare. REFERENCES 1Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, et al. PI-RADS prostate imaging—Reporting and data System: 2015, version 2. Eur Urol. 2016; 69: 16–40. 10.1016/j.eururo.2015.08.052 PubMedWeb of Science®Google Scholar 2Chesnais AL, Niaf E, Bratan F, Mège-Lechevallier F, Roche S, Rabilloud M, et al. Differentiation of transitional zone prostate cancer from benign hyperplasia nodules: evaluation of discriminant criteria at multiparametric MRI. Clin Radiol. 2013; 68: e323–e330. 10.1016/j.crad.2013.01.018 CASPubMedWeb of Science®Google Scholar 3Turkbey B, Rosenkrantz AB, Haider MA, et al. Prostate Imaging Reporting and Data System version 2.1: 2019 update of Prostate Imaging Reporting and Data System version 2. Eur Urol. 2019; 76: 340–351. 10.1016/j.eururo.2019.02.033 PubMedWeb of Science®Google Scholar 4Byun J, Park KJ, Kim MH, Kim JK. Direct comparison of PI-RADS version 2 and 2.1 in transition zone lesions for detection of prostate cancer: preliminary experience. J Magn Reason Imaging. 2020; 52: 577–586. 10.1002/jmri.27080 PubMedWeb of Science®Google Scholar 5Lim CS, Abreu-Gomez J, Carrion I, Schieda N. Prevalence of prostate cancer in PI-RADS version 2.1 transition zone atypical nodules upgraded by abnormal DWI: correlation with MRI-directed TRUS-guided targeted biopsy. Am J Roentgenol. 2021; 216: 683–690. 10.2214/AJR.20.23932 PubMedWeb of Science®Google Scholar 6Yilmaz EC, Shih JH, Belue MJ, Harmon SA, Phelps TE, Garcia C, et al. Prospective evaluation of PI-RADS version 2.1 for prostate cancer detection and investigation of multiparametric MRI-derived markers. Radiology. 2023; 307:e221309. 10.1148/radiol.221309 PubMedWeb of Science®Google Scholar 7Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA. The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma definition of grading patterns and proposal for a new grading System. Am J Surg Pathol. 2016; 40: 244–252. 10.1097/PAS.0000000000000530 PubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation